- Anti-angiogenic therapies in brain metastases
Anna S. Berghoff et al, 2018, memo - Magazine of European Medical Oncology CrossRef - Anti-angiogenics in Brain Metastases: Perspectives and Experiences
Frank Winkler, 2019, Tumor Angiogenesis CrossRef - First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis
Chu Zhang et al, 2020, Medicine CrossRef - Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis
Ping Liang et al, 2020, Open Medicine CrossRef - MODERN IDEAS ABOUT THE COMBINATION OF RADIATION THERAPY WITH ANTIANGIOGENIC DRUGS IN THE TREATMENT OF PATIENTS WITH BRAIN METASTASES
O. I. Kit et al, 2020, Siberian journal of oncology CrossRef - Newly developed anti-angiogenic therapy in non-small cell lung cancer
Jingjing Qu et al, 2018, Oncotarget CrossRef - Effect of pemetrexed on brain metastases from nonsmall cell lung cancer with wild-type and unknown EGFR status
Xiaoqing Yu et al, 2019, Medicine CrossRef - Antiangiogenics in Brain Metastases: Perspectives and Experiences
Frank Winkler, 2019, Tumor Angiogenesis CrossRef - Combinatorial treatment using bevacizumab/pemetrexed loaded core-shell silica nanoparticles for non-small cell lung cancer
Deepika Radhakrishnan et al, 2023, Science and Technology of Advanced Materials CrossRef